We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Pre-emptive Low-dose Doxycycline During Anti-EGFR Treatment (STLDD-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01380262
Recruitment Status : Unknown
Verified June 2011 by Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology.
Recruitment status was:  Recruiting
First Posted : June 27, 2011
Last Update Posted : June 27, 2011
Information provided by:
Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2011
  Estimated Study Completion Date : September 2011